Role of GALNT2 in the modulation of ENPP1 expression, and insulin signaling and action. GALNT2: A novel modulator of insulin signaling

Antonella Marucci, Flora Cozzolino, Claudia Dimatteo, Maria Monti, Piero Pucci, Vincenzo Trischitta, Rosa Di Paola

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Ectonucleotide pyrophosphatase phosphodiesterase 1 (ENPP1) inhibits insulin signaling and action. Understanding the mechanisms underlying ENPP1 expression may help unravel molecular mechanisms of insulin resistance. Recent data suggest a role of ENPP1-3'untraslated region (UTR), in controlling ENPP1 expression. We sought to identify trans-acting ENPP1-3'UTR binding proteins, and investigate their role on insulin signaling.By RNA pull-down, 49 proteins bound to ENPP1-3'UTR RNA were identified by mass spectrometry (MS). Among these, in silico analysis of genome wide association studies and expression profile datasets pointed to N-acetylgalactosaminyltransferase 2 gene (GALNT2) for subsequent investigations. Gene expression levels were evaluated by RT-PCR. Protein expression levels, IRS-1 and Akt phosphorylation were evaluated by Western blot. Insulin receptor (IR) autophosphorylation was evaluated by ELISA.GALNT2 down-regulation increased while GALNT2 over-expression reduced ENPP1 expression levels. In addition, GALNT2 down-regulation reduced insulin stimulation of IR, IRS-1 and Akt phosphorylation and insulin inhibition of phosphoenolpyruvate carboxykinase (PEPCK) expression, a key neoglucogenetic enzyme.Our data point to GALNT2 as a novel factor involved in the modulation of ENPP1 expression as well as insulin signaling and action in human liver HepG2 cells.

Original languageEnglish
Pages (from-to)1388-1395
Number of pages8
JournalBiochimica et Biophysica Acta - Molecular Cell Research
Volume1833
Issue number6
DOIs
Publication statusPublished - Jun 2013

Fingerprint

Insulin
Insulin Receptor
Down-Regulation
N-Acetylgalactosaminyltransferases
Phosphorylation
RNA
Phosphoenolpyruvate
ectonucleotide pyrophosphatase phosphodiesterase 1
Genome-Wide Association Study
Hep G2 Cells
Computer Simulation
Insulin Resistance
Mass Spectrometry
Carrier Proteins
Proteins
Western Blotting
Enzyme-Linked Immunosorbent Assay
Gene Expression
Polymerase Chain Reaction
Liver

Keywords

  • 3'UTR binding proteins
  • ENPP1
  • GALNT2
  • Insulin signaling

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology

Cite this

Role of GALNT2 in the modulation of ENPP1 expression, and insulin signaling and action. GALNT2 : A novel modulator of insulin signaling. / Marucci, Antonella; Cozzolino, Flora; Dimatteo, Claudia; Monti, Maria; Pucci, Piero; Trischitta, Vincenzo; Di Paola, Rosa.

In: Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1833, No. 6, 06.2013, p. 1388-1395.

Research output: Contribution to journalArticle

@article{d51ec6d3565b4337ab4144c4b67c2664,
title = "Role of GALNT2 in the modulation of ENPP1 expression, and insulin signaling and action. GALNT2: A novel modulator of insulin signaling",
abstract = "Ectonucleotide pyrophosphatase phosphodiesterase 1 (ENPP1) inhibits insulin signaling and action. Understanding the mechanisms underlying ENPP1 expression may help unravel molecular mechanisms of insulin resistance. Recent data suggest a role of ENPP1-3'untraslated region (UTR), in controlling ENPP1 expression. We sought to identify trans-acting ENPP1-3'UTR binding proteins, and investigate their role on insulin signaling.By RNA pull-down, 49 proteins bound to ENPP1-3'UTR RNA were identified by mass spectrometry (MS). Among these, in silico analysis of genome wide association studies and expression profile datasets pointed to N-acetylgalactosaminyltransferase 2 gene (GALNT2) for subsequent investigations. Gene expression levels were evaluated by RT-PCR. Protein expression levels, IRS-1 and Akt phosphorylation were evaluated by Western blot. Insulin receptor (IR) autophosphorylation was evaluated by ELISA.GALNT2 down-regulation increased while GALNT2 over-expression reduced ENPP1 expression levels. In addition, GALNT2 down-regulation reduced insulin stimulation of IR, IRS-1 and Akt phosphorylation and insulin inhibition of phosphoenolpyruvate carboxykinase (PEPCK) expression, a key neoglucogenetic enzyme.Our data point to GALNT2 as a novel factor involved in the modulation of ENPP1 expression as well as insulin signaling and action in human liver HepG2 cells.",
keywords = "3'UTR binding proteins, ENPP1, GALNT2, Insulin signaling",
author = "Antonella Marucci and Flora Cozzolino and Claudia Dimatteo and Maria Monti and Piero Pucci and Vincenzo Trischitta and {Di Paola}, Rosa",
year = "2013",
month = "6",
doi = "10.1016/j.bbamcr.2013.02.032",
language = "English",
volume = "1833",
pages = "1388--1395",
journal = "Biochimica et Biophysica Acta - Molecular Cell Research",
issn = "0167-4889",
publisher = "Elsevier",
number = "6",

}

TY - JOUR

T1 - Role of GALNT2 in the modulation of ENPP1 expression, and insulin signaling and action. GALNT2

T2 - A novel modulator of insulin signaling

AU - Marucci, Antonella

AU - Cozzolino, Flora

AU - Dimatteo, Claudia

AU - Monti, Maria

AU - Pucci, Piero

AU - Trischitta, Vincenzo

AU - Di Paola, Rosa

PY - 2013/6

Y1 - 2013/6

N2 - Ectonucleotide pyrophosphatase phosphodiesterase 1 (ENPP1) inhibits insulin signaling and action. Understanding the mechanisms underlying ENPP1 expression may help unravel molecular mechanisms of insulin resistance. Recent data suggest a role of ENPP1-3'untraslated region (UTR), in controlling ENPP1 expression. We sought to identify trans-acting ENPP1-3'UTR binding proteins, and investigate their role on insulin signaling.By RNA pull-down, 49 proteins bound to ENPP1-3'UTR RNA were identified by mass spectrometry (MS). Among these, in silico analysis of genome wide association studies and expression profile datasets pointed to N-acetylgalactosaminyltransferase 2 gene (GALNT2) for subsequent investigations. Gene expression levels were evaluated by RT-PCR. Protein expression levels, IRS-1 and Akt phosphorylation were evaluated by Western blot. Insulin receptor (IR) autophosphorylation was evaluated by ELISA.GALNT2 down-regulation increased while GALNT2 over-expression reduced ENPP1 expression levels. In addition, GALNT2 down-regulation reduced insulin stimulation of IR, IRS-1 and Akt phosphorylation and insulin inhibition of phosphoenolpyruvate carboxykinase (PEPCK) expression, a key neoglucogenetic enzyme.Our data point to GALNT2 as a novel factor involved in the modulation of ENPP1 expression as well as insulin signaling and action in human liver HepG2 cells.

AB - Ectonucleotide pyrophosphatase phosphodiesterase 1 (ENPP1) inhibits insulin signaling and action. Understanding the mechanisms underlying ENPP1 expression may help unravel molecular mechanisms of insulin resistance. Recent data suggest a role of ENPP1-3'untraslated region (UTR), in controlling ENPP1 expression. We sought to identify trans-acting ENPP1-3'UTR binding proteins, and investigate their role on insulin signaling.By RNA pull-down, 49 proteins bound to ENPP1-3'UTR RNA were identified by mass spectrometry (MS). Among these, in silico analysis of genome wide association studies and expression profile datasets pointed to N-acetylgalactosaminyltransferase 2 gene (GALNT2) for subsequent investigations. Gene expression levels were evaluated by RT-PCR. Protein expression levels, IRS-1 and Akt phosphorylation were evaluated by Western blot. Insulin receptor (IR) autophosphorylation was evaluated by ELISA.GALNT2 down-regulation increased while GALNT2 over-expression reduced ENPP1 expression levels. In addition, GALNT2 down-regulation reduced insulin stimulation of IR, IRS-1 and Akt phosphorylation and insulin inhibition of phosphoenolpyruvate carboxykinase (PEPCK) expression, a key neoglucogenetic enzyme.Our data point to GALNT2 as a novel factor involved in the modulation of ENPP1 expression as well as insulin signaling and action in human liver HepG2 cells.

KW - 3'UTR binding proteins

KW - ENPP1

KW - GALNT2

KW - Insulin signaling

UR - http://www.scopus.com/inward/record.url?scp=84875794049&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875794049&partnerID=8YFLogxK

U2 - 10.1016/j.bbamcr.2013.02.032

DO - 10.1016/j.bbamcr.2013.02.032

M3 - Article

C2 - 23500900

AN - SCOPUS:84875794049

VL - 1833

SP - 1388

EP - 1395

JO - Biochimica et Biophysica Acta - Molecular Cell Research

JF - Biochimica et Biophysica Acta - Molecular Cell Research

SN - 0167-4889

IS - 6

ER -